• 1
    Mankin HJ. The reaction of articular cartilage to injury and osteoarthritis (first of two parts). N Engl J Med 1974; 291: 128592.
  • 2
    Salter RB, Field P. The effects of continuous compression on living articular cartilage. J Bone Joint Surg Am 1960; 42: 319.
  • 3
    Wada J, Koshino T, Morii T, Sugimoto K. Natural course of osteoarthritis of the knee treated with or without intraarticular corticosteroid injections. Bull Hosp Jt Dis 1993; 53: 458.
  • 4
    Balch HW, Gibson JM, El-Ghobarey AF, Bain LS, Lynch MP. Repeated corticosteroid injections into knee joints. Rheumatol Rehabil 1977; 16: 13740.
  • 5
    Blyth T, Hunter JA, Stirling A. Pain relief in the rheumatoid knee after steroid injection: a single-blind comparison of hydrocortisone succinate, and triamcinolone acetonide or hexacetonide. Br J Rheumatol 1994; 33: 4613.
  • 6
    Cederlof S, Jonson G. Intraarticular prednisolone injection for osteoarthritis of the knee: a double blind test with placebo. Acta Chir Scand 1966; 132: 5327.
  • 7
    Dieppe PA, Sathapatayavongs B, Jones HE, Bacon PA, Ring EF. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil 1980; 19: 2127.
  • 8
    Friedman DM, Moore ME. The efficacy of intraarticular steroids in osteoarthritis: a double-blind study. J Rheumatol 1980; 7: 8506.
  • 9
    Gray RG, Gottlieb NL. Intra-articular corticosteroids: an updated assessment. Clin Orthop 1983; 23563.
  • 10
    Valtonen EJ. Clinical comparison of triamcinolonehexacetonide and betamethasone in the treatment of osteoarthrosis of the knee-joint. Scand J Rheumatol Suppl 1981; 41: 17.
  • 11
    Gaffney K, Ledingham J, Perry JD. Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. Ann Rheum Dis 1995; 54: 37981.
  • 12
    Jones A, Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis 1996; 55: 82932.
  • 13
    American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000; 43: 190515.
  • 14
    Behrens F, Shepard N, Mitchell N. Alterations of rabbit articular cartilage by intra-articular injections of glucocorticoids. J Bone Joint Surg Am 1975; 57: 706.
  • 15
    Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol 1999; 11: 41721.
  • 16
    Papachristou G, Anagnostou S, Katsorhis T. The effect of intraarticular hydrocortisone injection on the articular cartilage of rabbits. Acta Orthop Scand 1997; 1324.
  • 17
    Pelletier J-P, Martel-Pelletier J, Cloutier J-M, Woessner JF Jr. Proteoglycan-degrading acid metalloprotease activity in human osteoarthritic cartilage, and the effect of intraarticular steroid injections. Arthritis Rheum 1987; 30: 5418.
  • 18
    Pelletier J-P, Martel-Pelletier J. Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 1989; 32: 18193.
  • 19
    Pelletier J-P, Mineau F, Raynauld J-P, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J. Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 1994; 37: 41423.
  • 20
    Pelletier J-P, Di Battista JA, Raynauld J-P, Wilhelm S, Martel-Pelletier J. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1 and oncogene protein synthesis in experimental osteoarthritis. Lab Invest 1995; 72: 57886.
  • 21
    Williams JM, Brandt KD. Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damage. Arthritis Rheum 1985; 28: 126774.
  • 22
    Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 183340.
  • 23
    Altman RD, Fries JF, Bloch DA, Carstens J, Cooke TD, Genant H, et al. Radiographic assessment of progression in osteoarthritis. Arthritis Rheum 1987; 30: 121425.
  • 24
    Brandt KD, Fife RS, Braunstein EM, Katz B. Radiographic grading of the severity of knee osteoarthritis: relation of the Kellgren and Lawrence grade to a grade based on joint space narrowing, and correlation with arthroscopic evidence of articular cartilage degeneration. Arthritis Rheum 1991; 34: 13816.
  • 25
    Ravaud P, Ayral X, Dougados M. Radiologic progression of hip and knee osteoarthritis. Osteoarthritis Cartilage 1999; 7: 2229.
  • 26
    Lequesne M, Brandt K, Bellamy N, Moskowitz R, Menkes CJ, Pelletier J-P, et al. Guidelines for testing slow acting drugs in osteoarthritis. J Rheumatol Suppl 1994; 41: 6573.
  • 27
    Scott WW Jr, Lethbridge-Cejku M, Reichle R, Wigley FM, Tobin JD, Hochberg MC. Reliability of grading scales for individual radiographic features of osteoarthritis of the knee: the Baltimore longitudinal study of aging atlas of knee osteoarthritis. Invest Radiol 1993; 28: 497501.
  • 28
    Schouten JS, Van den Ouweland FA, Valkenburg HA. A 12 year follow up study in the general population on prognostic factors of cartilage loss in osteoarthritis of the knee. Ann Rheum Dis 1992; 51: 9327.
  • 29
    Spector TD, Dacre JE, Harris PA, Huskisson EC. Radiological progression of osteoarthritis: an 11 year follow up study of the knee. Ann Rheum Dis 1992; 51: 110710.
  • 30
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 103949.
  • 31
    Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957; 16: 494501.
  • 32
    Huskisson EC, Berry H, Gishen P, Jubb RW, Whitehead J, and the Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis Study Group. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. J Rheumatol 1995; 22: 19416.
  • 33
    Palmoski MJ, Brandt KD. Effects of some nonsteroidal antiinflammatory drugs on proteoglycan metabolism and organization in canine articular cartilage. Arthritis Rheum 1980; 23: 101020.
  • 34
    Rashad S, Revell P, Hemingway A, Low F, Rainsford K, Walker F. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 1989; 2: 51922.
  • 35
    Choquette D, Bellamy N, Raynauld JP. A French-Canadian version of the WOMAC Osteoarthritis Index [abstract]. Arthritis Rheum 1994; 37 Suppl 9: S226.
  • 36
    Buckland-Wright C. Protocols for precise radio-anatomical positioning of the tibiofemoral and patellofemoral compartments of the knee. Osteoarthritis Cartilage 1995; 3: 7180.
  • 37
    Buckland-Wright JC, Macfarlane DG, Williams SA, Ward RJ. Accuracy and precision of joint space width measurements in standard and macroradiographs of osteoarthritic knees. Ann Rheum Dis 1995; 54: 87280.
  • 38
    Lequesne M, Nguyen NJH, Rodriguez P, Masse JP, Glimet T. Vitesse du pincement de l'interligne au cours de la gonarthrose fémoro-tibiale interne: validité de la mesure [abstract]. Rev Rhum Mal Osteoartic 1990; 57: A14.
  • 39
    Revell PA, Mayston V, Lalor P, Mapp P. The synovial membrane in osteoarthritis: a histological study including the characterization of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis 1988; 47: 3007.
  • 40
    Haraoui B, Pelletier J-P, Cloutier J-M, Faure M-P, Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis: in vivo effects of antirheumatic drugs. Arthritis Rheum 1991; 34: 15363.
  • 41
    Lindblad S, Hedfors E. Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis. Arthritis Rheum 1987; 30: 10818.
  • 42
    Pelletier J-P, Howell DS. Etiopathogenesis of osteoarthritis. In: McCartyDJ, KoopmanWJ, editors. Arthritis and allied conditions: a textbook of rheumatology. 12th ed. Philadelphia: Lea & Febiger; 1993. p. 172334.
  • 43
    Di Battista JA, Martel-Pelletier J, Wosu LO, Sandor T, Antakly T, Pelletier J-P. Glucocorticoid receptor mediated inhibition of interleukin-1 stimulated neutral metalloprotease synthesis in normal human chondrocytes. J Clin Endocrinol Metab 1991; 72: 31626.
  • 44
    Di Battista JA, Martel-Pelletier J, Antakly T, Tardif G, Cloutier J-M, Pelletier J-P. Reduced expression of glucocorticoid receptor levels in human osteoarthritic chondrocytes: role in the suppression of metalloprotease synthesis. J Clin Endocrinol Metab 1993; 76: 112834.
  • 45
    Ravaud P, Moulinier L, Giraudeau B, Ayral X, Guerin C, Noel E, et al. Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum 1999; 42: 47582.
  • 46
    Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 357: 2516.